Dominant hereditary inclusion-body myopathy gene (IBM3) maps to chromosome region 17p13.1

Am J Hum Genet. 1999 May;64(5):1420-6. doi: 10.1086/302375.

Abstract

We recently described an autosomal dominant inclusion-body myopathy characterized by congenital joint contractures, external ophthalmoplegia, and predominantly proximal muscle weakness. A whole-genome scan, performed with 161 polymorphic markers and with DNA from 40 members of one family, indicated strong linkage for markers on chromosome 17p. After analyses with additional markers in the region and with DNA from eight additional family members, a maximum LOD score (Zmax) was detected for marker D17S1303 (Zmax=7.38; recombination fraction (theta)=0). Haplotype analyses showed that the locus (Genome Database locus name: IBM3) is flanked distally by marker D17S945 and proximally by marker D17S969. The positions of cytogenetically localized flanking markers suggest that the location of the IBM3 gene is in chromosome region 17p13.1. Radiation hybrid mapping showed that IBM3 is located in a 2-Mb chromosomal region and that the myosin heavy-chain (MHC) gene cluster, consisting of at least six genes, co-localizes to the same region. This localization raises the possibility that one of the MHC genes clustered in this region may be involved in this disorder.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromosome Mapping*
  • Chromosomes, Human, Pair 17 / genetics*
  • Contracture / congenital
  • Contracture / genetics*
  • Female
  • Genetic Markers
  • Haplotypes
  • Humans
  • Male
  • Muscle Weakness / genetics*
  • Muscular Atrophy / genetics*
  • Ophthalmoplegia / genetics*
  • Pedigree

Substances

  • Genetic Markers